LAKE FOREST, Ill.--(BUSINESS WIRE)--Akorn, Inc. (NASDAQ:AKRX) a specialty pharmaceutical company today announced that it has entered into a ten year exclusive contract manufacturing supply agreement with an undisclosed ophthalmic company.
LAKE FOREST, Ill.--(BUSINESS WIRE)--Akorn, Inc. (NASDAQ:AKRX) a specialty pharmaceutical company today announced that it has entered into a ten year exclusive contract manufacturing supply agreement with an undisclosed ophthalmic company.
